It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Image source: Getty Images
CSL Ltd (ASX: CSL)
According to a note out of Citi, its analysts have retained their buy rating and $225.00 price target on this biotherapeutics company's shares. The broker points out that CSL shares were sold off in 2025. This was due to concerns over margins, weak influenza vaccine demand, immunoglobulins growth, and Seqirus uncertainty. While this is disappointing, Citi believes there is scope for a recovery in 2026 even if its net profit doesn't grow in the double digits as per its medium-term target. Citi feels that rebuilding investor confidence will be more important than beating earnings estimates. The CSL share price ended the week at $181.42.
DroneShield Ltd (ASX: DRO)
A note out of Bell Potter reveals that its analysts have retained their buy rating and $5.00 price target on this counter-drone technology company's shares. This follows the release of another strong quarterly update from DroneShield last week. Bell Potter points out that the company's sales growth was stronger than it was expecting. While its sales pipeline has reduced meaningfully since October, which appears to have spooked the market, Bell Potter isn't concerned. The broker believes the sales pipeline reduction reflects the loss of low probability contracts or potential contracts that have been reduced in size. In addition, the broker once again reaffirms its belief that the company has a market leading offering and a competitive advantage owing to its years of battlefield experience. It thinks this bodes well for 2026 given how it believes this year will be an inflection point for the global C-UAS industry, with countries poised to unleash a wave of spending. The DroneShield share price ended the week at $3.32.
Liontown Ltd (ASX: LTR)
Another note out of Bell Potter reveals that its analysts have retained their buy rating on this lithium miner's shares with a trimmed price target of $2.42. The broker acknowledges that Liontown's quarterly update was softer than expected for production and revenues. However, it was pleased to see that its unit costs were better than expected. Looking ahead, Bell Potter points out that Liontown will be ramping up and de-risking its Kathleen Valley lithium project over the next 18 months. And given the current lithium price strength, it believes the company can rapidly generate cash to support incremental production expansions and shareholder returns. The Liontown share price was fetching $1.85 at Friday's close.
